Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
"He will be a great asset to Relief as aviptadil advances in clinical development in Europe and the U.S. and as we hopefully prepare submissions for marketing approval soon.” Said the Chairman of the board
Market Data 
Markets 
AI
